Thousands warned over vCJD
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Thousands of patients were warned today they may have been exposed to vCJD through blood plasma products.
Thousands of patients were warned today they may have been exposed to vCJD through blood plasma products.
The Department of Health said more than 6,000 people would receive letters explaining the situation and to help minimise the possibility of passing on the brain-wasting disease.
But Health Secretary John Reid and Chief Medical Officer Sir Liam Donaldson said it was a highly precautionary measure and the risk of any of these patients developing vCJD was very small.
It follows the first possible case of a person dying after contracting vCJD through a blood transfusion, announced by Dr Reid last December.
This led to a ban on people who have received a blood transfusion since January 1980 donating blood in the future.
Then in July it emerged that another patient who received donated blood was found to be carrying the vCJD agent, although they died of unrelated causes.
A risk assessment was ordered to look at blood plasma products - derived from donated blood and used in products such as clotting agents to treat haemophilia and other bleeding disorders.
Today Sir Liam said that 6,000 people with these conditions would receive letters telling them about the risk assessment exercise.
He estimated the number who may be affected directly to be around 4,000 people.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments